LENSAR (LNSR) Q4 2025 earnings summary

Executive summary

• The proposed acquisition by Alcon was terminated due to FTC opposition, leading to renewed independent operations and stakeholder support, with management committed to expanding the robotic laser cataract market.

• Despite acquisition-related uncertainty, the ALLY system's installed base grew 48% year-over-year, with a backlog of 13 pending installations at year-end.

• Recurring revenue for 2025 exceeded $46.3 million, a 15% increase over 2024, representing 79% of total revenue.

• Worldwide procedure volume rose 22% in 2025, with robust growth in both U.S. and international markets.

• LENSAR received a $10 million transaction deposit upon acquisition termination, strengthening its cash position.

Financial highlights

• Q4 2025 revenue was $16 million, a 4% year-over-year decline due to lower system sales, especially outside the U.S., partially offset by higher procedure revenue.

• Full-year 2025 revenue reached $58.4 million, up from $53.5 million in 2024.

• Q4 recurring revenue increased 17% year-over-year to $12.7 million; full-year recurring revenue up 15% to $46.3 million.

• Gross margin for 2025 was approximately 46%; Q4 gross margin was 43%.

• Adjusted EBITDA for Q4 2025 was $595,000, with positive adjusted EBITDA for the year despite $3.5 million in merger-related costs impacting SG&A.

Outlook and guidance

• Management expects a gradual return to historical operating performance through 2026, focusing on accelerating revenue growth, maintaining cost discipline, and enhancing cash flow.

• Forecasting gross margin percentage in the 46%-49% range for 2026, with higher system sales potentially lowering margin but boosting recurring revenue.

• Cash-based operating expenses projected to increase no more than 10% in 2026, mainly for commercial activities.

• International system sales expected to recover gradually as distributors reengage, with significant growth anticipated in Europe, Southeast Asia, and potential new markets.

• Continued focus on increasing ALLY adoption and utilization to drive recurring revenue growth.